News
MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of ...
New research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.
GLP-1 RAs may significantly increase the risk of neovascular age-related macular degeneration in older adults with diabetes.
Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...
T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 ...
Vertex is trimming its Rhode Island footprint on the back of a scrapped “cells plus device” program in diabetes, leaving 125 staffers out of a job. | The company is merging its three buildings at its ...
The layoffs will heavily affect Vertex’s operations in Rhode Island, where the biotech will consolidate three facilities into ...
Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...
Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...
Canadian researchers find that taking semaglutide increases the chances of developing neovascular age-related macular ...
Eight individuals, including employees from Dr Reddy's Lab, have been arrested for stealing Semaglutide powder worth over Rs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results